Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients

Chronobiology International

Volumn 28, Issue 10, 2011, Pages 841-851

  Mazzoccoli, G ^a   Panza, A ^b   Valvano, M R ^b   Palumbo, O ^c   Carella, M ^c   Pazienza, V ^b   Biscaglia, G ^b   Tavano, F ^a   Di Sebastiano, P ^a   Andriulli, A ^b   Piepoli, A ^b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b Gastroenterology Unit   (Italy)

^c Medical Genetics Unit   (Italy)

Author keywords

Cancer chronotherapy; Clock genes; Colorectal Cancer; Patients

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR CLOCK;

AGED; ARTICLE; COLORECTAL TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MICROSATELLITE INSTABILITY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

AGED; CLOCK PROTEINS; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; RNA, MESSENGER;

EID: 81255140206     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.3109/07420528.2011.615182     Document Type: Article

References (46)

1. Agostino PV, Harrington ME, Ralph MR, Golombek DA. (2009). Casein kinase-1-epsilon (CK1epsilon) and circadian photic responses in hamsters. Chronobiol. Int. 26:126-133.
2. Alhopuro P, Bjrklund M, Sammalkorpi H, Turunen M, Tuupanen S, Bistrm M, Niittymki I, Lehtonen HJ, Kivioja T, Launonen V, Saharinen J, Nousiainen K, Hautaniemi S, Nuorva K, Mecklin JP, Jrvinen H, Orntoft T, Arango D, Lehtonen R, Karhu A, Taipale J, Aaltonen LA. (2010). Mutations in the circadian gene CLOCK in colorectal cancer. Mol. Cancer Res. 8:952-960.
3. Antoch MP, Kondratov RV, Takahashi JS. (2005). Circadian clock genes as modulators of sensitivity to genotoxic stress. Cell Cycle 4:901-907. (Pubitemid 41359755)
4. Barber RD, Harmer DW, Coleman RA, Clark BJ. (2005). GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol. Genomics 21:389-395. (Pubitemid 40898499)
5. Bertagnolli MM, Niedzwiecki D, Compton CC, Hahn HP, Hall M, Damas B, Jewell SD, Mayer RJ, Goldberg RM, Saltz LB, Warren RS, Redston M. (2009). Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: cancer and Leukemia Group B Protocol 89803. J. Clin. Oncol. 27:1814-1821.
6. Boland CR, Thibodeau SN, Hamilton SR. (1998). A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58:5248-5257. (Pubitemid 28521189)
7. Bur IM, Cohen-Solal AM, Carmignac D, Abecassis PY, Chauvet N, Martin AO, van der Horst GT, Robinson IC, Maurel P, Mollard P, Bonnefont X. (2009). The circadian clock components CRY1 and CRY2 are necessary to sustain sex dimorphism in mouse liver metabolism. J. Biol. Chem. 284:9066-9073.
8. Chen-Goodspeed M, Lee CC. (2007). Tumor suppression and circadian function. J. Biol. Rhythms 22:291-298.
9. Chu G, Yoshida K, Narahara S, Uchikawa M, Kawamura M, Yamauchi N, Xi Y, Shigeyoshi Y, Hashimoto S, Hattori MA. (2011). Alterations of circadian clockworks during differentiation and apoptosis of rat ovarian cells. Chronobiol. Int. 28:477-487.
10. Climent J, Perez-Losada J, Quigley DA, Kim IJ, Delrosario R, Jen KY, Bosch A, Lluch A, Mao JH, Balmain A. (2010). Deletion of the PER3 gene on chromosome 1p36 in recurrent ER-positive breast cancer. J. Clin. Oncol. 28:3770-3778.
11. Duguay D, Cermakian N. (2009). The crosstalk between physiology and circadian clock proteins. Chronobiol. Int. 26:1479-1513.
12. Edery I. (2000). Circadian rhythms in a nutshell. Physiol. Genomics 3:59-74.
13. Eide EJ, Vielhaber EL, Hinz WA, Virshup DM. (2002). The circadian regulatory proteins BMAL1 and cryptochromes are substrates of casein kinase I?. J. Biol. Chem. 277:17248-17254. (Pubitemid 34967759)
14. Erren TC, Gro JV, Meyer-Rochow VB.2011). Light, clocks, mood, and cancer: consolidation and novel tests of latitude and instability hypotheses. Chronobiol. Int. 28:471-473.
15. Filipski E, King VM, Li XM, Granda TG, Mormont MC, Liu X. (2002). Host circadian clock as a control point in tumor progression. J. Natl. Cancer Inst. 94:690-697. (Pubitemid 34552490)
16. Filipski E, King VM, Etienne MC, Li XM, Claustrat B, Granda TG. (2004). Persistent twenty-four hour changes in liver and bone marrow despite suprachiasmatic nuclei ablation in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287:R844-R851. (Pubitemid 39280471)
17. Fu L, Lee CC. (2003). The circadian clock: pacemaker and tumour suppressor. Nat. Rev. Cancer 3:350-361. (Pubitemid 37328855)
18. Fu L, Pelicano H, Liu J, Huang P, Lee CC. (2002). The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111:41-50.
19. Giacchetti S, Bjarnason G, Garufi C, Genet D, Iacobelli S, Tampellini M, Smaaland R, Focan C, Coudet B, Humblet Y, Canon JL, Adenis A, Lo Re G, Carvalho C, Schueller J, Anciaux N, Lentz MA, Baron B, Gorlia T, Levi F. (2006). Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group. J. Clin. Oncol. 24:3562-3569. (Pubitemid 46630527)
20. Gorbacheva VY, Kondratov RV, Zhang R, Cherukuri S, Gudkov AV, Takahashi JS, Antoch MP. (2005). Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex. Proc. Natl. Acad. Sci. U. S. A. 102:3407-3412. (Pubitemid 40328058)
21. Hastings MH, Reddy AB, Maywood ES. (2003). A clockwork web: circadian timing in brain and periphery, in health and disease. Nat. Rev. Neurosci. 4:649-661. (Pubitemid 37280160)
22. Hayashida S, Kuramoto Y, Koyanagi S, Oishi K, Fujiki J, Matsunaga N, Ikeda E, Ohdo S, Shimeno H, Soeda S. (2010). Peroxisome proliferator- activated receptor-? mediates high-fat, diet-enhanced daily oscillation of plasminogen activator inhibitor-1 activity in mice. Chronobiol. Int. 27:1735-1753.
23. Hrushesky WJ, Grutsch J, Wood PA, Yang X, Oh EY, Ansell C, Kidder S, Ferrans C, Quiton DF, Reynolds J, Du-Quiton J, Levin R, Lis C, Braun D. (2009). Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms. Integr. Cancer Ther. 8:387-397.
24. Huang TS, Grodeland G, Sleire L, Wang MY, Kvalheim G, Laerum OD. (2009). Induction of circadian rhythm in cultured human mesenchymal stem cells by serum shock and cAMP analogs in vitro. Chronobiol. Int. 26:242-257
25. Hunt T, Sassone-Corsi P. (2007). Riding tandem: circadian clocks and the cell cycle. Cell 129:461-464. (Pubitemid 46660976)
26. IARC (International Agency for Research on Cancer). (2010). Monographs on the evaluation of carcinogenic risks to humans. Volume 98.
27. Lyon, France: International Agency for Research on Cancer. Im JS, Jung BH, Kim SE, Lee KH, Lee JK. (2010). Per3, a circadian gene, is required for Chk2 activation in human cells. FEBS Lett. 584:4731-4734.
28. Iurisci I, Filipski E, Sallam H, Harper F, Guettier C, Maire I, Hassan M, Iacobelli S, Lvi F. (2009). Liver circadian clock, a pharmacologic target of cyclin-dependent kinase inhibitor seliciclib. Chronobiol. Int. 26:1169-1188.
29. Jud C, Chappuis S, Revell VL, Sletten TL, Saaltink DJ, Cajochen C, Skene DJ, Albrecht U. (2009). Age-dependent alterations in human PER2 levels after early morning blue light exposure. Chronobiol. Int. 26:1462-1469.
30. Kemp MG, Akan Z, Yilmaz S, Grillo M, Smith-Roe SL, Kang TH, Cordeiro-Stone M, Kaufmann WK, Abraham RT, Sancar A, Unsal- Kamaz K. (2010). Tipin-replication protein A interaction mediates Chk1 phosphorylation by ATR in response to genotoxic stress. J. Biol. Chem. 285:16562-16571.
31. Kloog I, Haim A, Stevens RG, Portnov BA. (2009). Global co-distribution of light at night (LAN) and cancers of prostate, colon, and lung in men. Chronobiol. Int. 26:108-125.
32. Koch JM, Hagenauer MH, Lee TM. (2009). The response of Per1 to light in the suprachiasmatic nucleus of the diurnal degu (Octodon degus). Chronobiol. Int. 26:1263-1271.
33. Kondratov RV, Antoch MP. (2007). Circadian proteins in the regulation of cell cycle and genotoxic stress responses. Trends Cell Biol. 17:311-317. (Pubitemid 47102196)
34. Krugluger W, Brandstaetter A, Kllay E, Schueller J, Krexner E, Kriwanek S, Bonner E, Cross HS. (2007). Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors. Cancer Res. 67:7917-7922. (Pubitemid 47281388)
35. Lee CC. (2006). Tumor suppression by the mammalian Period genes. Cancer Causes Control 17:525-530.
36. Leibetseder V, Humpeler S, Svoboda M, Schmid D, Thalhammer T, Zuckermann A, Marktl W, Ekmekcioglu C. (2009). Clock genes display rhythmic expression in human hearts. Chronobiol. Int. 26:621-636.
37. Lemmer B. (2009). Discoveries of rhythms in human biological functions: A historical review. Chronobiol. Int. 26:1019-1068.
38. Levi F, Schibler U. (2007). Circadian rhythms: mechanisms and therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 47:593-628.
39. Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T). Method. Methods 25:402-408. (Pubitemid 34164012)
40. Lowrey PL, Takahashi JS. (2000). Genetics of the mammalian circadian system: photic entrainment, circadian pacemaker mechanisms, and posttranslational regulation. Annu. Rev. Genet. 34:533-562. (Pubitemid 32065932)
41. Luo Y, Tian W, Cai L, Wang Y, Zhang J, Teng H, Du J, Sun ZS. (2009). Expression profiling reveals a positive regulation by mPer2 on circadian rhythm of cytotoxicity receptors: Ly49C and Nkg2d. Chronobiol. Int. 26:1514-1544.
42. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H.2003) Control mechanism of the circadian clock for timing of cell division in vivo. Science 302:255-259. (Pubitemid 37248750)
43. Mendoza J, Challet E (2009). Brain clocks: from the suprachiasmatic nuclei to a cerebral network. Neuroscientist 15:477-488.
44. Modak C, Chai J. (2009). Potential of casein kinase I in digestive cancer screening. World J. Gastrointest. Oncol. 15:26-33.
45. Mostafaie N, Kllay E, Sauerzapf E, Bonner E, Kriwanek S, Cross HS, Huber KR, Krugluger W. (2009). Correlated downregulation of estrogen receptor beta and the circadian clock gene Per1 in human colorectal cancer. Mol. Carcinog. 48:642-647.
46. Nagoshi E, Saini C, Bauer C, Laroche T, Naef F, Schibler U (2004). Circadian gene expression in individual fibroblasts: cell-autonomous and self-sustained oscillators pass time to daughter cells. Cell 119:693-705. (Pubitemid 39535756)